Markey, Kate A., Kuns, Rachel D., Browne, Daniel J., Gartlan, Kate H., Robb, Renee J., Martins, J. Paulo, Henden, Andrea S., Minnie, Simone A., Cheong, Melody, Koyama, Motoko, Smyth, Mark J., Steptoe, Raymond J., Belz, Gabrielle T., Brocker, Thomas, Degli-Esposti, Mariapia A., Lane, Steven W., and Hill, Geoffrey R. (2018) Flt-3L expansion of recipient CD8α+ dendritic cells deletes alloreactive donor T cells and represents an alternative to posttransplant Cyclophosphamide for the prevention of GVHD. Clinical Cancer Research, 24 (7). pp. 1604-1616.

Markey, Kate A., Burman, Angela C., Banovic, Tatjana, Kuns, Rachel D., Raffelt, Neil C., Rowe, Vanessa, Olver, Stuart D., Don, Alistair L.J., Morris , Edward S., Pettit, Alison R., Wilson, Yana A., Robb, Renee J., Randall, Louise M., Korner, Heinrich, Engwerda, Christian R., Clouston, Andrew D., MacDonald, Kelli P.A., and Hill, Geoffrey R. (2010) Soluble lymphotoxin is an important effector molecule in GVHD and GVL. Blood, 115 (1). pp. 122-132.